Blood Glucose Monitoring Systems Market by Product (CGM and SMBG), Type, Testing Site, Modality, Patient Care Setting, Distribution Channel, Application and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030

Blood Glucose Monitoring Systems Market Size

The global blood glucose monitoring systems market size was valued at $12.87 billion in 2024 and is projected to reach $25.13 billion by 2030, growing at a CAGR of 11.8% during the forecast period.

Blood Glucose Monitoring Systems Market Dynamics

• The blood glucose monitoring systems market has a promising growth potential due to several factors which include an increase in incidences of diabetes, the need for proper diabetes management, and the necessity of glucose management systems that quickly and effectively control blood glucose.

• Additionally, growing levels among hospitalized patients who experience hyperglycemia or hypoglycemia and increasing demand for monitoring systems because of population growth are expected to augment the market growth.

• However, unawareness of the blood glucose monitoring systems in many locations worldwide and lower diagnosis and treatment in emerging countries are the major factors hampering the market growth.

• On the contrary, the expansion of in-home blood glucose monitoring systems for household patients suffering from glucose imbalances provides profitable opportunities to the blood glucose monitoring system market.

Blood Glucose Monitoring Systems Market Overview

A blood glucose monitoring system is a device that is used to monitor the sugar level in the blood and for effective diabetes diagnosis and treatment. It may also be used as part of the care for people with diabetes mellitus type 1 or type 2 who have poor control of their blood sugar levels, though its use in the latter case is now rarely practiced.

By Product, Continuous Glucose Monitoring Systems to Grow at a Faster Pace

The continuous glucose monitoring (CGM) system segment is expected to grow at a higher rate, this is mainly attributed to the rising adoption of CGMs in developed and emerging countries. It can monitor the patient's blood glucose level regularly. Due to their ability to be easily use, minimally invasive procedures, and faster rates, CGMs are used more effectively than SMBGs in managing type 1 diabetes.

By Region, North America Region Dominates the Global Market Place

The market for blood glucose monitoring systems is dominated by the North American region. The rise in the number of diabetic patients, increased acceptance of technologically sophisticated medical equipment, well-developed healthcare infrastructure, and treatment costs in the region are all contributing to the this region growth. Furthermore, attractive reimbursements from health authorities, numerous government awareness initiatives, and an increasing number of Food and Drug Administration (FDA) approvals of blood glucose monitors are likely to drive the market expansion.

Some of the key players profiled in the Report:

• Abbott Laboratories
• B. Braun Melsungen AG
• Dexcom, Inc.
• F. Hoffmann-La Roche Ltd
• Ascensia Diabetes Care Holdings AG
• LifeScan, Inc.
• Medtronic
• Senseonics, Inc.
• Terumo Corporation
• Johnson & Johnson Services Inc
• Monarch Medical Technologies
• DarioHealth Corp
• Glytec Systems
• PHC Holdings Corporation
• Sanofi

Market Segmentation:

The research report includes in-depth coverage of the industry analysis with size, share, and forecast for the below segments:

Market by, Product    
• Continuous Glucose Monitoring (CGM) System
• Self-Monitoring Blood Glucose (SMBG) System

Market by, Type
• Non-invasive
• Invasive

Market by, Testing Type  
• Alternate Site Testing
• Fingertip testing

Market by, Modality    
• Wearable
• Non-wearable

Market by, Patient Care Setting     
• Self/Home Care
• Hospital & Clinics

Market by, Distribution Channel
• Institutional Sales
• Retail Sales

Market by, Application  
• Type 2 Diabetes
• Type 1 Diabetes
• Gestational Diabetes

Market by, Geography:

The wearable medical devices market report also analyzes the major geographic regions and countries of the market. The regions and countries covered in the study include:

• North America (The United States, Canada, Mexico), Market Estimates, Forecast & Opportunity Analysis
• Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Market Estimates, Forecast & Opportunity Analysis
• Asia Pacific (China, Japan, India, South Korea, Australia, New Zealand, Rest of Asia Pacific), Market Estimates, Forecast & Opportunity Analysis
• South America (Brazil, Argentina, Chile, Rest of South America), Market Estimates, Forecast & Opportunity Analysis
• Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, Rest of Middle East & Africa), Market Estimates, Forecast & Opportunity Analysis

What Can be Explored with this Research Report:

• Understand the key trends that will drive the market and the challenges it faces in the current market scenario
• Identify growth opportunities
• Porter’s five force analysis
• In-depth analysis of market segments, and regions/countries predicted to observe promising growth
• Historical and forecast size of the market in terms of revenue (USD Million)
• Company profiling with key products and solution offerings, key financial information, SWOT analysis, and business strategies adopted

Table Of Content

1 Market Overview           
    1.1 Introduction       
    1.2 Research Objectives      
    1.3 Market Segmentation      
    1.4 Stakeholders       
    1.5 List of Abbreviations
              
2 Executive Summary           
             
3 Research Methodology          
    3.1 Identification of Data      
    3.2 Evaluation of Market Dynamics     
    3.3 Collaboration of Data      
    3.4 Verification and Analysis      
    3.5 Data Sources       
    3.6 Assumptions       
             
4 Market Dynamics           
    4.1 Market Drivers       
           4.1.1 Increase in incidences of diabetes and the need for proper diabetes management
           4.1.2 Necessity of glucose management systems that quickly and effectively control blood glucose
    4.2 Market Restraints       
           4.2.1 Lower diagnosis and treatment in emerging countries
    4.3 Market Opportunities      
           4.3.1 Expansion of in-home blood glucose monitoring systems for household patients
    4.4 Market Challenges       
           4.4.1 Invasiveness of blood glucose monitors
    4.5 Impact of COVID-19 on Blood Glucose Monitoring Systems Market  
             
5 Porter's Five Force Analysis          
    5.1 Bargaining Power of Suppliers      
    5.2 Bargaining Power of Buyers      
    5.3 Threat of New Entrants      
    5.4 Threat of Substitutes      
    5.5 Competitive Rivalry in the Market     
             
6 Global Blood Glucose Monitoring Systems Market by, Product      
    6.1 Overview       
    6.2 Continuous Glucose Monitoring (CGM) System    
    6.3 Self-Monitoring Blood Glucose (SMBG) System    
             
7 Global Blood Glucose Monitoring Systems Market by, Type       
    7.1 Overview       
    7.2 Non-invasive       
    7.3 Invasive        
             
8 Global Blood Glucose Monitoring Systems Market by, Testing Site      
    8.1 Overview       
    8.2 Alternate Site Testing      
    8.3 Fingertip testing       
             
9 Global Blood Glucose Monitoring Systems Market by, Modality      
    9.1 Overview       
    9.2 Wearable       
    9.3 Non-wearable       
             
10 Global Blood Glucose Monitoring Systems Market by, Patient Care Setting     
    10.1 Overview       
    10.2 Self/Home Care       
    10.3 Hospital & Clinics       
             
11 Global Blood Glucose Monitoring Systems Market by, Distribution Channel     
    11.1 Overview       
    11.2 Institutional Sales       
    11.3 Retail Sales       
             
12 Global Blood Glucose Monitoring Systems Market by, Application      
    12.1 Overview       
    12.2 Type 2 Diabetes       
    12.3 Type 1 Diabetes       
    12.4 Gestational Diabetes      
             
13 Global Blood Glucose Monitoring Systems Market by, Geography      
    13.1 Overview       
    13.2 North America       
    13.3 Europe        
    13.4 Asia Pacific       
    13.5 South America       
    13.6 Middle East & Africa      
             
14 Key Developments           
             
15 Company Profiling           
    15.1 Abbott Laboratories       
             15.1.1 Business Overview
             15.1.2 Product/Service Offering
             15.1.3 Financial Overview
             15.1.4 SWOT Analysis
             15.1.5 Key Activities
    15.2 B. Braun Melsungen AG      
    15.3 Dexcom, Inc.       
    15.4 F. Hoffmann-La Roche Ltd      
    15.5 Ascensia Diabetes Care Holdings AG     
    15.6 LifeScan, Inc.       
    15.7 Medtronic       
    15.8 Senseonics, Inc.       
    15.9 Terumo Corporation      
    15.10 Johnson & Johnson Services Inc     
    15.11 Monarch Medical Technologies     
    15.12 DarioHealth Corp       
    15.13 Glytec Systems       
    15.14 PHC Holdings Corporation      
    15.15 Sanofi